This move is archived. Current quotes and coverage live on the stock page.
Follow WAVE
Waverley Pharma Inc faced a significant setback in its stock performance.
Waverley Pharma Inc (WAVE.V) saw a sharp decline of 25% in its stock price during yesterday's trading session, closing at just CA$0.01. This drop raises concerns for investors about the company's stability and future prospects.
Waverley Pharma Inc
WAVE.V
WAVE.V
Waverley Pharma Inc
WealthAwesomeMarket cap
$540,000
52W high
$0.03
52W low
$0.01
1W change
+100.00%
Beta
1.46
Analyst Price Targets
Based on analyst covering WAVE · as of Sep 17, 2026
Wall Street analysts forecast WAVE stock price to rise 49900.0% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$10.00
+49900.0% Upside
Current Price
C$0.02
Last close
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on WAVE's historical volatility
30-Day Vol
518.1%
Annualized
90-Day Vol
520.6%
Annualized
Trend (90d)
+50.0%
Annualized drift
90d Mean
C$0.02
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$0.02 | C$0.00 – C$0.13 |
| 60 trading days | C$0.02 | C$0.00 – C$0.28 |
| 90 trading days | C$0.02 | C$0.00 – C$0.53 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Investor takeaway: Investors should be cautious with Waverley Pharma Inc, especially given its recent performance and the absence of news explaining the drop.
Waverley Pharma Inc's stock fell 25% yesterday.
With a market cap of only CA$810,000, Waverley Pharma's financial health is under scrutiny.
Bull case
If Waverley Pharma can effectively utilize its recent acquisitions and improve its financial performance, there may be a chance for recovery.
Bear case
The lack of clarity surrounding the stock's decline, combined with a negative profit margin and a low market cap, indicates significant risks for investors.
Understanding the Decline
Waverley Pharma's stock price fell sharply yesterday, closing at CA$0.01. This 25% drop raises concerns about the company's market position and investor confidence. The absence of any significant news or announcements during the trading session has left many investors puzzled about the reasons behind this steep decline.
Financial Health Overview
With a market cap of CA$810,000 and a profit margin of -63.4%, Waverley Pharma's financial metrics indicate underlying issues. The company's P/E ratio stands at 0, reflecting a lack of profitability. Investors should closely monitor these figures as they assess whether to hold or purchase WAVE.V shares.
Future Considerations
Despite the recent downturn, Waverley Pharma has made strides in expanding its presence, such as its acquisition of C & R Pharmacy. However, the company's ability to recover from this stock drop will depend on its strategic execution and financial management moving forward. Investors should stay informed about any developments that could impact the stock's trajectory.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
